Recombinant proteins find widespread use in diagnostic applications, pharmaceuticals and research activities. They are used for developing new biopharmaceuticals which are utilized for treatment of cancer, infectious diseases and other therapeutic areas. Some key benefits of recombinant proteins include high purity, consistency in composition and ability to produce biologically active forms of human proteins in other organisms like E.coli and yeast. The increasing R&D investments by biopharmaceutical companies for development of novel biologics is augmenting the demand for recombinant proteins. The global Recombinant Protein Market is estimated to be valued at US$ 3131.37 Mn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The increasing demand for biopharmaceuticals for treatment and management of various chronic diseases represents a key opportunity for growth of the Global Recombinant Protein Market Size. Biologics have revolutionized treatment landscapes of various therapeutic areas. Recombinant proteins play a vital role in development of biopharmaceuticals including monoclonal antibodies, vaccines, growth factors and various other therapeutic molecules. According to a report by Evaluate Pharma, global sales of biologics are estimated to reach US$ 401 Bn by 2026, reflecting a CAGR of 8-10%. The robust pipeline of biologics along with increasing demand to control diseases like cancer, diabetes and autoimmune disorders is expected to substantially boost utilization of recombinant proteins during research, development and production of novel biologics. This thus presents a lucrative opportunity for players in the recombinant protein market to further capitalize on.

Porter’s Analysis

Threat of new entrants: The threat of new entrants into the recombinant protein market is low as it requires high R&D investment and manufacturing infrastructure to produce high quality recombinant proteins.
Bargaining power of buyers: The bargaining power of buyers is high as there are many established players providing recombinant proteins. Buyers can negotiate on price and demand customization of products.
Bargaining power of suppliers: The bargaining power of suppliers is medium as there are several suppliers providing critical raw materials required for production of recombinant proteins.
Threat of new substitutes: The threat of new substitutes is medium as there is continuous research for developing new and improved drug delivery methods.
Competitive rivalry: The competitive rivalry in the market is high due to presence of many global and regional players offering a wide range of recombinant proteins.

Get More Insights On This Topic: https://medicalinfoblogs.weebly.com/blog/recombinant-protein-market-growth-accelerated-by-rising-demand-for-next-generation-therapeutics